Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collagen arthritis--what can it teach us?

N A Staines1, P H Wooley

  • 1Division of Life Sciences, King's College London.

British Journal of Rheumatology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis.

Clinical and experimental immunology·2014
Same author

Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening.

Gene therapy·2012
Same author

Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model.

Gene therapy·2010
Same author

Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.

Annals of the rheumatic diseases·2005
Same author

A novel murine model of orthopaedic wear-debris associated osteolysis.

Scandinavian journal of rheumatology·2004
Same author

Increased dermal elastic fibers in the tight skin mouse.

Clinical and experimental rheumatology·2004
Same journal

Sensorineural hearing loss, iritis and ankylosing spondylitis.

British journal of rheumatology·1999
Same journal

Outcome in systemic vasculitis.

British journal of rheumatology·1999
Same journal

Infection with an unenveloped DNA virus (TTV) associated with non-A to G hepatitis in patients with rheumatoid arthritis.

British journal of rheumatology·1999
Same journal

Aortitis in relapsing polychondritis.

British journal of rheumatology·1999
Same journal

Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis.

British journal of rheumatology·1999
Same journal

Haemophagocytic syndrome in a patient with dermatomyositis.

British journal of rheumatology·1999
See all related articles

Collagen-induced arthritis in animal models offers insights into human autoimmune diseases. Therapies targeting immune responses and inducing tolerance show promise for controlling arthritis.

Area of Science:

  • Immunology
  • Rheumatology
  • Translational Medicine

Background:

  • Collagen-induced arthritis (CIA) is a widely used animal model for studying human autoimmune arthritis.
  • CIA shares immunological parallels with human rheumatoid arthritis, making it valuable for therapeutic research.

Purpose of the Study:

  • To review the key features of CIA relevant to human disease.
  • To discuss the application of experimental therapies tested in CIA models for human arthritis treatment.

Main Methods:

  • Review of existing literature on CIA and its immunological basis.
  • Analysis of therapeutic strategies including antibodies against lymphocyte markers (e.g., CD4, CD40L, MHC Class II) and cytokine manipulation (e.g., TNF-alpha, IL-1, IL-2).
  • Evaluation of antigen-specific tolerance induction via mucosal collagen delivery.

Related Experiment Videos

Main Results:

  • Antibodies targeting CD4, CD40L, and MHC Class II demonstrate disease suppression in CIA models.
  • Cytokine modulation (TNF-alpha, IL-1, IL-2) shows varied but promising results in controlling arthritis progression.
  • Mucosal administration of collagen induces antigen-specific tolerance, effectively suppressing CIA.

Conclusions:

  • CIA serves as a critical preclinical model for understanding and treating human autoimmune arthritis.
  • Therapeutic approaches targeting immune pathways and inducing tolerance hold significant potential for clinical application in arthritis management.